Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Common Stock | Options Exercise | $436K | +23.1K | +3285.92% | $18.87 | 23.8K | May 10, 2022 | Direct | F1 |
transaction | MRNA | Common Stock | Sale | -$435K | -3.2K | -13.43% | $136.10 | 20.6K | May 10, 2022 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Stock Option (Right to Buy) | Options Exercise | $0 | -23.1K | -58.16% | $0.00 | 16.6K | May 10, 2022 | Common Stock | 23.1K | $18.87 | Direct | F1, F4 |
Id | Content |
---|---|
F1 | The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 9, 2022. |
F2 | Represents the number of shares sold by the Reporting Person to cover the payment of the exercise price of the option. |
F3 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.10 to $136.17. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
F4 | This option is fully vested and exercisable. |